S&P 5007,691▲ 0.41%Nasdaq26,431▲ 1.11%Dow Jones51,966▼ 0.07%Nasdaq 10029,529▲ 1.17%VIX18.44▼ 7.75%US Dollar101.97▲ 0.13%Gold spot4,165▲ 0.21%WTI spot101.91▲ 1.04%
Home › 145020 › Research report
← 145020 page
XStocksXray
Market X-Ray report · 19 October 2026

Hugel Inc (145020)

KOSDAQ · Korea · prices in KRW · close of 19 Oct 2026

Key indicators

Last closeKRW 187,000.00
52-week range163,700.00 – 308,500.00
Return, 1 month / 3 months−19.4% / −17.6%
Return, 1 year / 3 years−38.1% / +69.5%
TrendBelow its 200-day average
RSI (14)42
Volatility (1 year)57.8%
Worst drawdown (1 year)-43.4%
Average daily value traded11,553.94M KRW
Dividend yield–

Market X-Ray price-based

59/ 100 · High confidence · ahead of 66% of stocks on this exchange
Trend55
Momentum34
Stability (higher is calmer)68
Liquidity94
Income–

Five-year price chart navy: price · brown: 200-day average

83,568163,984244,400324,816405,2322021-102023-012024-042025-072026-10

About the company

Hugel Inc is a South Korean pharmaceutical company based in the city of Chuncheon. It develops and makes botulinum toxin products used for cosmetic wrinkle treatment and for therapeutic purposes, and it also produces hyaluronic acid dermal fillers. Its customers include clinics, hospitals and distributors in Korea and in overseas markets, where its aesthetic products are used by medical professionals. The company focuses on research, manufacturing and supply of these injectable treatments.

On this site Hugel Inc appears as a stock on the KOSDAQ (Korea), code 145020, with prices in South Korean won (KRW). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Hugel Inc (145020) trades on the KOSDAQ in Korea. It last closed at KRW 187,000.00 on 19 October 2026.

Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 616 of 1,830 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 38.1% and over the last three months it fell 17.6%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Hugel Inc (145020)

The five lenses in numbers each metric is ranked against the other stocks on KOSDAQ

Lens and metricValueScoreReading
Trend55 · FairMixed trend against its averages.
Above 200-day average-23.8%
From 52-week high-37.1%
Momentum34 · WeakLagging most stocks on this exchange.
3-month return-17.6%
6-month return-26.7%
12-month return, skipping the last month-23.2%
Stability (higher is calmer)68 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)57.8%
Worst drawdown, 1 year (smaller is calmer)-43.4%
Liquidity94 · StrongTrades actively.
Average daily value traded11,553.94M KRW
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Liquidity: Trades actively.

Weak spots

  • Momentum: Lagging most stocks on this exchange.

Returns

1 week+3.9%
1 month−19.4%
3 months−17.6%
6 months−26.7%
1 year−38.1%
3 years+69.5%
5 years–

Signals

50-day / 200-day average226,312.00 / 245,448.00
Golden / death cross (60 days)Death, 27 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)9,057.33

Technical summary

DailyBearish3 bullish · 2 neutral · 11 bearish
WeeklyStrongly bearish0 bullish · 1 neutral · 11 bearish
MonthlyStrongly bearish0 bullish · 1 neutral · 7 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on KOSDAQ; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 20 Oct 2026